Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Balducci

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|July 24, 2019
Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and NeuroinflammationClaudia Balducci, Gianluigi Forloni
Pharmacological Research|February 3, 2018
Novel targets in Alzheimer's disease: A special focus on microgliaClaudia Balducci, Gianluigi Forloni
Prion|December 15, 2010
β-amyloid oligomers and prion protein: Fatal attraction?Gianluigi Forloni, Claudia Balducci
Neuromolecular Medicine|December 15, 2010
APP transgenic mice: their use and limitationsClaudia Balducci, Gianluigi Forloni
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease, Oligomers, and InflammationGianluigi Forloni, Claudia Balducci
Current Pharmaceutical Design|July 18, 2013
In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approachesClaudia Balducci, Gianluigi Forloni
Frontiers in Aging Neuroscience|November 5, 2019
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?Milica Cerovic, Gianluigi Forloni, Claudia Balducci
Frontiers in Neuroscience|September 9, 2022
<i>Oligomeropathies</i>, inflammation and prion protein bindingGianluigi Forloni, Pietro La Vitola, Claudia Balducci
Journal of the Peripheral Nervous System : JPNS|January 29, 2016
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathiesFrancesca Gallia, Claudia Balducci, Eduardo Nobile-Orazio
Prion|January 18, 2013
The neurodegeneration in Alzheimer disease and the prion proteinGianluigi Forloni, Alessandra Sclip, Tiziana Borsello, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|July 24, 2019
Doxycycline for Alzheimer's Disease: Fighting β-Amyloid Oligomers and NeuroinflammationClaudia Balducci, Gianluigi Forloni
Pharmacological Research|February 3, 2018
Novel targets in Alzheimer's disease: A special focus on microgliaClaudia Balducci, Gianluigi Forloni
Prion|December 15, 2010
β-amyloid oligomers and prion protein: Fatal attraction?Gianluigi Forloni, Claudia Balducci
Neuromolecular Medicine|December 15, 2010
APP transgenic mice: their use and limitationsClaudia Balducci, Gianluigi Forloni
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease, Oligomers, and InflammationGianluigi Forloni, Claudia Balducci
Current Pharmaceutical Design|July 18, 2013
In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approachesClaudia Balducci, Gianluigi Forloni
Frontiers in Aging Neuroscience|November 5, 2019
Neuroinflammation and the Gut Microbiota: Possible Alternative Therapeutic Targets to Counteract Alzheimer's Disease?Milica Cerovic, Gianluigi Forloni, Claudia Balducci
Frontiers in Neuroscience|September 9, 2022
<i>Oligomeropathies</i>, inflammation and prion protein bindingGianluigi Forloni, Pietro La Vitola, Claudia Balducci
Journal of the Peripheral Nervous System : JPNS|January 29, 2016
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune-mediated neuropathiesFrancesca Gallia, Claudia Balducci, Eduardo Nobile-Orazio
Prion|January 18, 2013
The neurodegeneration in Alzheimer disease and the prion proteinGianluigi Forloni, Alessandra Sclip, Tiziana Borsello, et al.
Pageof 8